AG
TGX

Algert Global’s THERAGENICS CORP TGX Stock Holding History

Algert Global’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-89,833
Closed -$186K – 385
2013
Q2 		$186K Buy
+89,833
New +$161K 0.06% 251

Other funds holding TGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LOM
Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Algert Global's TGX Position: Q3 2013 in Review

Algert Global sold out of THERAGENICS CORP (TGX) in Q3 2013, closing a stake of 89,833 shares — an estimated $186K sold.

Algert Global first reported a position in TGX in Q2 2013 and held it in 1 quarter. The position peaked at $186K in Q2 2013. 41 funds tracked by Wall St. Rank hold TGX as of Q3 2013.

  • Algert Global reported no remaining THERAGENICS CORP position as of Q3 2013 after selling out during the quarter.
  • Algert Global sold 89,833 THERAGENICS CORP shares in Q3 2013, an estimated $186K.
  • Algert Global first reported a position in THERAGENICS CORP in Q2 2013 and held it in 1 quarter.
  • Algert Global's THERAGENICS CORP position peaked at $186K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q3 2013.

Based on Algert Global's 13F filing for Q3 2013, filed 12 Nov 2013.